SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Xenova (XNVA)
An SI Board Since October 2002
Posts SubjectMarks Bans Symbol
173 11 0 XNVA
Emcee:  nigel bates Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
73could be a combination of the forbes article that probably drove folks to take amopgcw-7/14/2004
72I found that too, but that wouldn't be enough to move the stock 20 cents afttom pope-7/14/2004
71Forbes: Quitter's Aid Kerry A. Dolan, 07.26.04 A nicotine vaccine may hemopgcw-7/14/2004
70There is apparently a Forbes article on the company which led to trades going oftom pope-7/14/2004
69Successful Results from Second Clinical Trial of Anti-Smoking Vaccine, TA-NIC nigel bates-7/14/2004
68Found this on the yahoo XNVA thread. Doesn't say much, except that the Transtom pope-7/11/2004
67Would like very much to have gone, but sadly I don't have time at the momentnigel bates-6/30/2004
66Wonder what the drug lords (both pharma & colombian) think of this. ImagineExtra Pale-6/29/2004
65 >>Published online before print June 28, 2004 Proc. Natl. Acad. Sci. USAtuck-6/28/2004
64Going? >>SLOUGH, U.K., June 24, 2004 (PRIMEZONE) -- Xenova Group plc (Lontuck-6/24/2004
63Dunno, I don't remember or never knew how big the market is supposed to be. tuck-6/21/2004
62Pretty decent results, but will anyone partner it ?nigel bates-6/14/2004
61>>SLOUGH, U.K., June 14, 2004 (PRIMEZONE) -- Xenova Group plc (London:XEN.tuck-6/14/2004
60Xenova and FDA reach agreement on SPA Phase III trial programme for TransMID -- nigel bates-5/11/2004
59Xenova Group plc First Quarter Results, 2004 SLOUGH, U.K., May 6, 2004 (PRIMEZnigel bates-5/6/2004
58<i>Also, FWIW...</i> Abstract Number: 509 Use of pheophorbide a, anigel bates-5/3/2004
57That's what I'm hoping (nb - Xenova retains full rights outside of US atnigel bates-4/30/2004
56Mlnm annual report lists development of Mln944 as "high priority" withExtra Pale-4/30/2004
55"...data asco 944 in solid tumors..." Message 20075690 (thanks as usuanigel bates-4/30/2004
54Xenova Signs Lease Agreement with Genzyme SLOUGH, U.K., April 7, 2004 (PRIMEZOnigel bates-4/7/2004
53Managed to find a bit of data on the Transmid PI and PII trials, but you must betuck-2/24/2004
52Transmid Boy, has this one been kicking around for a while: >>J Neurosurtuck-2/24/2004
51<i>Buying ahead of the results ??</i> Xenova Group plc -- Preliminanigel bates-2/24/2004
50what made this stock go up 15% today ?Madharry-2/24/2004
49biz.yahoo.com I noticed this yesterday and added to my position again-becoming Madharry-2/19/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News